California State Teachers Retirement System (CalSTRS)
CADL icon

California State Teachers Retirement System (CalSTRS)’s Candel Therapeutics CADL Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57K Sell
638
-1,734
-73% -$13.1K ﹤0.01% 2436
2026
Q1 		$11.6K Sell
2,372
-327
-12% -$1.78K ﹤0.01% 2628
2025
Q4 		$15.2K Buy
2,699
+243
+10% +$1.31K ﹤0.01% 2625
2025
Q3 		$12.5K Buy
2,456
+2
+0.1% +$12 ﹤0.01% 2753
2025
Q2 		$12.4K Buy
2,454
+839
+52% +$4.32K ﹤0.01% 2660
2025
Q1 		$9.13K Hold
1,615
– – ﹤0.01% 2783
2024
Q4 		$14K Buy
1,615
+179
+12% +$1.06K ﹤0.01% 2741
2024
Q3 		$9.95K Hold
1,436
– – ﹤0.01% 2877
2024
Q2 		$8.9K Buy
+1,436
New +$10.8K ﹤0.01% 2935

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s CADL Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Candel Therapeutics (CADL) stake by 73% in Q2 2026, selling an estimated $13.1K and leaving 638 shares worth $6.57K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.

California State Teachers Retirement System (CalSTRS) first reported a position in CADL in Q2 2024 and has held it in 9 quarters since. The position peaked at $15.2K in Q4 2025. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 638 shares of Candel Therapeutics worth $6.57K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,734 Candel Therapeutics shares in Q2 2026, an estimated $13.1K.
  • Candel Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2436 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Candel Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Candel Therapeutics position peaked at $15.2K in Q4 2025.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.